183 related articles for article (PubMed ID: 18948190)
1. RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.
Malaval C; Laffargue M; Barbaras R; Rolland C; Peres C; Champagne E; Perret B; Tercé F; Collet X; Martinez LO
Cell Signal; 2009 Jan; 21(1):120-7. PubMed ID: 18948190
[TBL] [Abstract][Full Text] [Related]
2. Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F
Cardouat G; Duparc T; Fried S; Perret B; Najib S; Martinez LO
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):832-841. PubMed ID: 28504211
[TBL] [Abstract][Full Text] [Related]
3. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis.
Martinez LO; Jacquet S; Esteve JP; Rolland C; Cabezón E; Champagne E; Pineau T; Georgeaud V; Walker JE; Tercé F; Collet X; Perret B; Barbaras R
Nature; 2003 Jan; 421(6918):75-9. PubMed ID: 12511957
[TBL] [Abstract][Full Text] [Related]
4. The β-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells.
Cavelier C; Ohnsorg PM; Rohrer L; von Eckardstein A
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):131-9. PubMed ID: 21979433
[TBL] [Abstract][Full Text] [Related]
5. The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.
Jacquet S; Malaval C; Martinez LO; Sak K; Rolland C; Perez C; Nauze M; Champagne E; Tercé F; Gachet C; Perret B; Collet X; Boeynaems JM; Barbaras R
Cell Mol Life Sci; 2005 Nov; 62(21):2508-15. PubMed ID: 16231090
[TBL] [Abstract][Full Text] [Related]
6. Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes.
Fabre AC; Vantourout P; Champagne E; Tercé F; Rolland C; Perret B; Collet X; Barbaras R; Martinez LO
Cell Mol Life Sci; 2006 Dec; 63(23):2829-37. PubMed ID: 17103109
[TBL] [Abstract][Full Text] [Related]
7. Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells.
Dada LA; Novoa E; Lecuona E; Sun H; Sznajder JI
J Cell Sci; 2007 Jul; 120(Pt 13):2214-22. PubMed ID: 17550967
[TBL] [Abstract][Full Text] [Related]
8. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
9. P2Y13 receptor is critical for reverse cholesterol transport.
Fabre AC; Malaval C; Ben Addi A; Verdier C; Pons V; Serhan N; Lichtenstein L; Combes G; Huby T; Briand F; Collet X; Nijstad N; Tietge UJ; Robaye B; Perret B; Boeynaems JM; Martinez LO
Hepatology; 2010 Oct; 52(4):1477-83. PubMed ID: 20830789
[TBL] [Abstract][Full Text] [Related]
10. Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.
Martinez LO; Najib S; Perret B; Cabou C; Lichtenstein L
Atherosclerosis; 2015 Jan; 238(1):89-100. PubMed ID: 25437896
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
Hardy AR; Hill DJ; Poole AW
Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
[TBL] [Abstract][Full Text] [Related]
12. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
13. A negative modulatory role for rho and rho-associated kinase signaling in delamination of neural crest cells.
Groysman M; Shoval I; Kalcheim C
Neural Dev; 2008 Oct; 3():27. PubMed ID: 18945340
[TBL] [Abstract][Full Text] [Related]
14. Functional role of RhoA in growth regulation of primary hepatocytes.
Dohda T; Nakamura Y; Kamihira M; Iijima S
J Biochem; 2004 May; 135(5):631-7. PubMed ID: 15173202
[TBL] [Abstract][Full Text] [Related]
15. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
16. Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.
Hoffmann K; Sixel U; Di Pasquale F; von Kügelgen I
Biochem Pharmacol; 2008 Nov; 76(10):1201-13. PubMed ID: 18809389
[TBL] [Abstract][Full Text] [Related]
17. Leptin-mediated cytoskeletal remodeling in chondrocytes occurs via the RhoA/ROCK pathway.
Liang J; Feng J; Wu WK; Xiao J; Wu Z; Han D; Zhu Y; Qiu G
J Orthop Res; 2011 Mar; 29(3):369-74. PubMed ID: 20886658
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells.
Buvinic S; Bravo-Zehnder M; Boyer JL; Huidobro-Toro JP; González A
J Cell Sci; 2007 Dec; 120(Pt 24):4289-301. PubMed ID: 18057028
[TBL] [Abstract][Full Text] [Related]
19. RhoE controls myoblast alignment prior fusion through RhoA and ROCK.
Fortier M; Comunale F; Kucharczak J; Blangy A; Charrasse S; Gauthier-Rouvière C
Cell Death Differ; 2008 Aug; 15(8):1221-31. PubMed ID: 18369372
[TBL] [Abstract][Full Text] [Related]
20. Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor.
Ding Z; Kim S; Kunapuli SP
Mol Pharmacol; 2006 Jan; 69(1):338-45. PubMed ID: 16234484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
